UK | Norway | Netherlands | Poland | Germany | |||||
---|---|---|---|---|---|---|---|---|---|
Rec. | Mean (SD) | Rec. | Mean (SD) | Rec. | Mean (SD) | Rec. | Mean (SD) | Rec. | Mean (SD) |
Determine degree of overweight | 72.4% (+10.2) | Social contact | 80.8% (+15.2) | BP control in raised risk | 83.0% (+5.8) | Smoking cessation counseling | 83.4% (+4.8) | Structured medication counseling | 66.6% (+19.7) |
Assess willingness to change | 71.1% (+6.8) | Collaborative care | 59.8% (+17.3) | BP control in cardiovascular disease | 87.7% (+3.5) | Grade breathless | 86.3% (+5.4) | Use of medication schedules | 92.2% (+6.1) |
Offer management | 78.8% (+4.4) | Depression care manager | 51.0% (+28.3) | Cholesterol control in raised risk | 78.9% (+6.1) | Information for the patient | 87.9% (+5.3) | Avoid inadequate medication | 59.4% (+15.2) |
Consider referral | 53.1% (+24.9) | Counseling | 72.2% (+11.5) | Cholesterol control in cardiovascular disease | 88.2% (+2.1) | Inhaler use education | 91.8% (+4.2) | Â | Â |
 |  | Mild depression | 58.4% (+16.4) | Lifestyle advice | 81.4% (+2.5) |  |  |  |  |
 |  | Severe depression, recurrent or chronic depression, dysthymia | 47.4% (+21.5) | Assess risk in chronic kidney disease | 75.1% (+6.4) |  |  |  |  |